FindTrial
Sign In

Comparison of the efficacy and safety of URSL, RPLU, and MPCNL for treatment of large upper impacted ureteral stones: A Randomized Controlled Trial

Comparison of the efficacy and safety of URSL, RPLU, and MPCNL for treatment of large upper impacted ureteral stones: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011507
Enrollment
Unknown
Registered
2017-05-26
Start date
2012-01-02
Completion date
Unknown
Last updated
2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

upper impacted ureteral stones

Interventions

1:MPCNL
2:URSL
3:RPLU

Sponsors

Huai'an first people’s hospital, Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
22 Years to 69 Years

Inclusion criteria

Inclusion criteria: patients with a single upper ureteral stone (located below the ureteropelvic junction to the superior aspect of sacroiliac joint); the stone was >15 mm along its longest diameter as revealed by kidney-ureter-bladder (KUB) abdominal plain film.

Exclusion criteria

Exclusion criteria: patients with a history of any intervention operation on the corresponding ureter, radiolucent stones, active infection, or urinary tract abnormalities, coagulopathy, or pregnancy.

Design outcomes

Primary

MeasureTime frame
stone clearance rate;—

Countries

China

Contacts

Public ContactWANG YUN YAN

Huai'an first people’s hospital, Nanjing Medical University

yunyanwang2000@163.com+86 13505239046

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 9, 2026